Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...
Intellomx Launches Swarm-Based AI Platform to Accelerate and De-Risk Novel Target and Drug Discovery
Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic target identification capability. Intellomx now offers an end-to-end AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback